Author:
Kamal A M,Bulmer J N,DeCruze S B,Stringfellow H F,Martin-Hirsch P,Hapangama D K
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB (2002) Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Mod Pathol 15: 365–371.
2. Alkushi A, Köbel M, Kalloger SE, Gilks CB (2010) High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes. Int J Gynecol Pathol 29: 343–350.
3. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10–17.
4. Breast Cancer Consensus C, Clinical Oncological Society Of A, Australian New Zealand Breast Cancer Trials G (1994) Consensus Report from Australia’s First National Breast Cancer Consensus Conference, June 15–17 1994. Australian-New Zealand Breast Cancer Trials Group: Newcastle, NSW, Australia.
5. Cancer Research UK (2013) Cancer Stats Report: Uterine (Womb) Cancer [online] Available at http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer#heading-Zero (accessed on June 2015).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献